This invention discloses a
Chlamydomonas reinhardtii synergistic
exosome hydrogel microneedle, its preparation method, and its application, belonging to the field of biomedical materials and microneedle delivery technology. The hydrogel microneedles prepared in this invention use methacryloxymethyl
carboxymethyl chitosan and methacryloxyhyaluronic acid as the
hydrogel matrix. After adding a
photoinitiator to the
hydrogel matrix, the microneedles are obtained through molding and
ultraviolet crosslinking. The tips of the hydrogel microneedles are loaded with
Chlamydomonas reinhardtii exosomes to improve transdermal
delivery efficiency. The backing layer or matrix portion of the hydrogel microneedles is loaded with
Chlamydomonas reinhardtii to maintain its photosynthetic activity and provide continuous local
oxygen supply. This invention constructs a multifunctional therapeutic
system for the synergistic effect of
Chlamydomonas reinhardtii and exosomes. This
system integrates in-situ photosynthetic
oxygen supply,
exosome anti-inflammatory repair, and local microneedle delivery onto the same platform, and can simultaneously intervene in key aspects of
osteoarthritis such as hypoxia,
inflammation, and insufficient
tissue repair, showing promising application prospects.